Product Information
FT CHILD ALLERGY RLF 5 MG CHEW is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.5212 per EA under NDC 70677104301. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on Jun 12, 2019.
Strength
5 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677104301
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORATADINEApproval Type
Generic (ANDA)
FDA Application
ANDA210033FDA Approved
6/12/2019
On Market Since
10/30/2023
Price Statistics
The NADAC for FT CHILD ALLERGY RLF 5 MG CHEW has been published 107 times since Sep 18, 2024, and over the history we have for it it has risen 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5212 per EA |
|---|---|
| All-time high | $0.5301 (Aug 12, 2026) |
| All-time low | $0.4531 (Sep 18, 2024) |
| 52-week high | $0.5301 |
| 52-week low | $0.4757 |
| Median price | $0.4757 |
| Average price | $0.4845 |
| Largest weekly change | +2.4% (Feb 18, 2026) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the loratadine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
loratadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT CHILD ALLERGY RLF 5 MG CHEW?
The current National Average Drug Acquisition Cost (NADAC) for FT CHILD ALLERGY RLF 5 MG CHEW, manufactured by Strategic Sourcing Services LLC, is $0.5212 per EA (NDC 70677104301), effective Sep 30, 2026.
How has the price of FT CHILD ALLERGY RLF 5 MG CHEW changed over time?
Over the history we have for it, the NADAC for FT CHILD ALLERGY RLF 5 MG CHEW has risen 15.0%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for FT CHILD ALLERGY RLF 5 MG CHEW?
Since Sep 18, 2024, the NADAC for FT CHILD ALLERGY RLF 5 MG CHEW has ranged from a low of $0.4531 (Sep 18, 2024) to a high of $0.5301 (Aug 12, 2026), with a median of $0.4757 per EA.
Are there cheaper alternatives to FT CHILD ALLERGY RLF 5 MG CHEW?
No other NADAC-published product currently shares the active ingredient and strength of FT CHILD ALLERGY RLF 5 MG CHEW in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FT CHILD ALLERGY RLF 5 MG CHEW?
FT CHILD ALLERGY RLF 5 MG CHEW (NDC 70677104301) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.